Trial Profile
A Study to Evaluate the Outcomes after Using Fidaxomicin in Patients with Recurrent Clostridium difficile Associated Diarrhoea (CDAD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- 22 Dec 2015 New trial record